Previous Close | 9.24 |
Open | 9.18 |
Bid | 8.75 x 800 |
Ask | 8.76 x 900 |
Day's Range | 8.68 - 9.20 |
52 Week Range | 8.68 - 22.87 |
Volume | |
Avg. Volume | 2,553,790 |
Market Cap | 558.869M |
Beta (5Y Monthly) | 2.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.46 |
Earnings Date | Nov 07, 2023 - Nov 13, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.95 |
Subscribe to Yahoo Finance Plus to view Fair Value for BYND
The Covid trade is out. Investors have piled into bets against Novavax, [the struggling vaccine developer](https://www.wsj.com/livecoverage/stock-market-news-today-02-28-2023/card/novavax-shares-slammed-in-late-trading-after-going-concern-warning-myWePGCVFJtdDTPQalW2) that was late to market with its Covid-19 vaccine.
Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?
In this article, we will take a look at the 10 blue-chip stocks at all-time lows. To see more such companies, go directly to 5 Blue-Chip Stocks at All-Time Lows. The inflation storm and subsequent rate hikes by the Federal Reserve have left investors on the back foot as a strange skepticism has taken over […]